Profound Medical (TSX:PRN) 3-Year FCF Growth Rate : 3.10% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Profound Medical 3-Year FCF Growth Rate?

Profound Medical's Free Cash Flow per Share for the three months ended in Dec. 2023 was C$-0.44.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 3.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 10 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Profound Medical was 21.40% per year. The lowest was 2.40% per year. And the median was 11.15% per year.

Competitive Comparison of Profound Medical's 3-Year FCF Growth Rate

For the Medical Devices subindustry, Profound Medical's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Profound Medical's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Profound Medical's 3-Year FCF Growth Rate falls into.

Profound Medical 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

Profound Medical (TSX:PRN) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.

Profound Medical 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Profound Medical's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Profound Medical (TSX:PRN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (TSX:PRN) » Definitions » 3-Year FCF Growth Rate

Comparable Companies

Traded in Other Exchanges

PROF:USA

Address

2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5

Website

https://www.profoundmedical.com

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.